• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Tissue Regeneration Systems

J&J’s DePuy picks up bioresorbable 3D printing tech from Tissue Regeneration Systems

April 20, 2017 By Fink Densford

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it acquired 3D printing technology assets from Tissue Regeneration Systems for an undisclosed amount. DePuy said it will use the technology to create patient-specific, bioresorbable implants for correcting orthopedic and craniomaxillofacial deformities and injuries. “We are systematically investing in building a pipeline of 3D printed products. The TRS […]

Filed Under: Business/Financial News, Orthopedics Tagged With: depuysynthes, Johnson and Johnson, Tissue Regeneration Systems

Tissue Regeneration System, Materialise ink deal to print tracheal splints

December 7, 2015 By Fink Densford

Belgium-based additive manufacturer and 3D printing company Materialise said today it inked a deal with Tissue Regeneration Systems to create 3D-printed tracheal splints for use in clinical trials. Materialise said its Mimics Innovation Suite was used to design the stent, constructed from a bioresorbable platform licensed to TRS from the University of Michigan in 2007. […]

Filed Under: Business/Financial News, Research & Development, Stents Tagged With: Materialise, Tissue Regeneration Systems

Amniox Medical taps ex-Smith & Nephew honcho Dugan for CEO | Personnel Moves

January 14, 2015 By Brad Perriello Leave a Comment

Amniox Medical taps ex-Smith & Nephew exec Dugan for CEO | Personnel Moves

Filed Under: News Well Tagged With: Amniox Medical, Arrhythmia Research Technology Inc., depuysynthes, Echo Therapeutics Inc., Johnson and Johnson, Nuvasive, OMNIlife Science Inc., Personnel Moves, Pro-Dex Inc., Senseonics, Smith & Nephew, SynCardia, Tissue Regeneration Systems, Unilife Corp.

FDA clears 3D-printed skull fillers by Tissue Regeneration Systems

August 30, 2013 By Ingrid Mezo Leave a Comment

FDA clears 3D-printed skull fillers by Tissue Regeneration Systems

Tissue Regeneration Systems won FDA clearance for its 3D-printed Cranial Bone Void Filler, the flagship product in a suite of devices indicated for cranial reconstruction.

Designed to fill holes left behind after surgery, the CBV filler appears to be the 1st 3D-printed device of its kind to get the FDA’s green light for the U.S. market.

Filed Under: Food & Drug Administration (FDA), News Well, Orthopedics, Regulatory/Compliance Tagged With: Tissue Regeneration Systems

Tissue Regeneration Systems closes $4.6M round

August 20, 2013 By Sony Salzman Leave a Comment

Tissue Regeneration Systems closes $4.6M funding round

Startup medical device company Tissue Regeneration Systems raised $4.6 million in an equity financing round led by Venture Investors, CEO Jim Fitzsimmons told MassDevice.com.

The round was also supported by the Wisconsin Alumni Research Foundation, the University of Michigan and the state of Wisconsin, Fitzsimmons told us.

Filed Under: Funding Roundup, News Well Tagged With: Resorbable bone materials, Tissue Regeneration Systems, Venture Capital/Private Equity

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy